Camilla Lomholt Kjersgaard
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Camilla Lomholt Kjersgaard has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Cecilia Høst Ramlau-Hansen
Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus, Denmark
5 shared publications Linn Håkonsen Arendt
Department of Public Health, Research Unit for Epidemiology Aarhus University Aarhus Denmark
4 shared publications- Andreas Ernst
Department of Urology, Aarhus University Hospital, Palle Juul-Jensens Blvd. 35, 8200 Aarhus N, Denmark; Department of Clinical Medicine, Aarhus University, Palle Juul-Jensens Blvd. 82, 8200 Aarhus N, Denmark
3 shared publications Andreas Ernst
Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus, Denmark
2 shared publicationsJørn Olsen
Department of Public Health, Research Unit for Epidemiology, Aarhus University, Aarhus, Denmark
2 shared publications- Katrine Strandberg-Larsen
Section of Epidemiology, Department of Public Health, University of Copenhagen , Copenhagen
2 shared publications
Latest Publications
- Open Access
- 25 February 2026
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (4) , 595-605
Prenatal exposure to parental smoking and infertility in sons and daughters: a cohort study
STUDY QUESTION: Is prenatal exposure to parental smoking associated with infertility in sons and daughters? SUMMARY ANSWER: The study does not provide robust evidence that prenatal smoking exposure increases the risk of infertility, defined as clinically diagnosed infertility or ART use, in adult sons and daughters. WHAT IS KNOWN ALREADY: Reproductive function is established early in fetal life and may be adversely affected by prenatal exposure to parental smoking. STUDY DESIGN, SIZE, DURATION: In this cohort study, we used data from the Danish birth cohort, Health Habits for Two, established in 1984–1987. In total, 11 980 (87% of eligible) women participated and gave birth to 11 144 liveborn, singleton sons and daughters. PARTICIPANTS/MATERIALS, SETTING, METHODS: Adult sons and daughters born to mothers enrolled in the birth cohort constituted the study population and were aged 35–38 years at follow-up. Around gestational week 36, mothers provided information on parental smoking. The primary exposure of interest was maternal smoking. Paternal smoking and combined parental smoking were also assessed to explore individual and potential synergistic effects. Infertility among offspring was defined as either an ICD-10 infertility diagnoses or use of ART, identified within two nationwide registers and considering their partners’ records. Associations were examined using Cox regression models estimating crude and adjusted hazard ratios (HRs) for categories of prenatal smoking, with non-smoking as the reference, accounting for competing risks of infertility. Dose–response associations were explored across categories of maternal and paternal smoking. The proportional hazards assumption was met only when stratifying analyses by age, using cutoffs of ≤26 and >26 years for sons, and ≤27 and >27 years for daughters. In a sensitivity analysis, follow-up was restricted to periods of registered partnership under the assumption that individuals in a relationship are more likely to be identified as infertile and vice versa. In a sub-analysis, analyses were stratified by offspring educational level to explore potential social gradients in being identified as infertile in medical records. MAIN RESULTS AND THE ROLE OF CHANCE: Maternal smoking of >9 cigarettes/day tended to be associated with higher risk of infertility among sons ≤26 years (HR 1.7 (95% CI: 0.8–3.5)) and daughters ≤27 years (HR 1.2 (95% CI: 0.7–1.9)), both indicating suggestive dose–response patterns with higher risk of infertility with increasing maternal smoking levels. No associations for sons >26 years or daughters >27 years were observed. Paternal smoking of >10 cigarettes/day tended to be associated with higher risk of infertility among sons >26 years (HR 1.3 (95% CI: 0.9–1.8)), indicating suggestive dose–response patterns. No higher risk of infertility following paternal smoking was observed among sons ≤26 years or daughters at any age. No synergistic effects of combined parental smoking were observed. When redefining the time at risk using the partnership model, we did not observe higher risks of infertility among maternally exposed sons and daughters. When stratifying the main analyses by the sons’ and daughters’ educational level, we observed tendencies of higher risks for infertility in some exposure groups among those with longer education. Overall, we found no robust evidence that prenatal exposure to parental smoking is associated with a higher risk of clinically recognized infertility in offspring. LIMITATIONS, REASONS FOR CAUTION: Parental smoking was self-reported by mothers late in pregnancy and might be subject to misclassification, most likely non-differential. Not all infertility cases may be captured in the registers as it requires pregnancy attempt and pursuing medical treatment. Most confidence intervals overlapped the null, indicating that the findings are also compatible with no association. Some analyses, particularly the stratified analyses, were limited by low statistical power. WIDER IMPLICATIONS OF THE FINDINGS: The observed diminishing effect estimates with increasing age for those exposed to maternal smoking may reflect growing influence from other dominant infertility risk factors. Results from analyses stratified by offspring educational level may be indicative of tendencies of greater awareness of fertility issues and higher health care-seeking among individuals from more advantaged socioeconomic backgrounds. A potential higher, although modest and uncertain, risk of infertility following prenatal smoking exposure cannot be excluded, supporting the current guidelines recommending smoking cessation prior to pregnancy. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the European Union (ERC, BIOSFER, 101071773); expressed views and opinions are however those of the authors’ only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them. Additionally, this study received funding from Aarhus University and was supported by the Research Council of Norway, through its Centre of Excellence funding scheme (No. 262700). All authors have no conflicts or interests to declare. TRIAL REGISTRATION NUMBER: N/A.
- 25 February 2026
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 41 (4) , 595-605
Open AccessPrenatal exposure to parental smoking and infertility in sons and daughters: a cohort study
STUDY QUESTION: Is prenatal exposure to parental smoking associated with infertility in sons and daughters? SUMMARY ANSWER: The study does not provide robust evidence that prenatal smoking exposure increases the risk of infertility, defined as clinically diagnosed infertility or ART use, in adult sons and daughters. WHAT IS KNOWN ALREADY: Reproductive function is established early in fetal life and may be adversely affected by prenatal exposure to parental smoking. STUDY DESIGN, SIZE, DURATION: In this cohort study, we used data from the Danish birth cohort, Health Habits for Two, established in 1984–1987. In total, 11 980 (87% of eligible) women participated and gave birth to 11 144 liveborn, singleton sons and daughters. PARTICIPANTS/MATERIALS, SETTING, METHODS: Adult sons and daughters born to mothers enrolled in the birth cohort constituted the study population and were aged 35–38 years at follow-up. Around gestational week 36, mothers provided information on parental smoking. The primary exposure of interest was maternal smoking. Paternal smoking and combined parental smoking were also assessed to explore individual and potential synergistic effects. Infertility among offspring was defined as either an ICD-10 infertility diagnoses or use of ART, identified within two nationwide registers and considering their partners’ records. Associations were examined using Cox regression models estimating crude and adjusted hazard ratios (HRs) for categories of prenatal smoking, with non-smoking as the reference, accounting for competing risks of infertility. Dose–response associations were explored across categories of maternal and paternal smoking. The proportional hazards assumption was met only when stratifying analyses by age, using cutoffs of ≤26 and >26 years for sons, and ≤27 and >27 years for daughters. In a sensitivity analysis, follow-up was restricted to periods of registered partnership under the assumption that individuals in a relationship are more likely to be identified as infertile and vice versa. In a sub-analysis, analyses were stratified by offspring educational level to explore potential social gradients in being identified as infertile in medical records. MAIN RESULTS AND THE ROLE OF CHANCE: Maternal smoking of >9 cigarettes/day tended to be associated with higher risk of infertility among sons ≤26 years (HR 1.7 (95% CI: 0.8–3.5)) and daughters ≤27 years (HR 1.2 (95% CI: 0.7–1.9)), both indicating suggestive dose–response patterns with higher risk of infertility with increasing maternal smoking levels. No associations for sons >26 years or daughters >27 years were observed. Paternal smoking of >10 cigarettes/day tended to be associated with higher risk of infertility among sons >26 years (HR 1.3 (95% CI: 0.9–1.8)), indicating suggestive dose–response patterns. No higher risk of infertility following paternal smoking was observed among sons ≤26 years or daughters at any age. No synergistic effects of combined parental smoking were observed. When redefining the time at risk using the partnership model, we did not observe higher risks of infertility among maternally exposed sons and daughters. When stratifying the main analyses by the sons’ and daughters’ educational level, we observed tendencies of higher risks for infertility in some exposure groups among those with longer education. Overall, we found no robust evidence that prenatal exposure to parental smoking is associated with a higher risk of clinically recognized infertility in offspring. LIMITATIONS, REASONS FOR CAUTION: Parental smoking was self-reported by mothers late in pregnancy and might be subject to misclassification, most likely non-differential. Not all infertility cases may be captured in the registers as it requires pregnancy attempt and pursuing medical treatment. Most confidence intervals overlapped the null, indicating that the findings are also compatible with no association. Some analyses, particularly the stratified analyses, were limited by low statistical power. WIDER IMPLICATIONS OF THE FINDINGS: The observed diminishing effect estimates with increasing age for those exposed to maternal smoking may reflect growing influence from other dominant infertility risk factors. Results from analyses stratified by offspring educational level may be indicative of tendencies of greater awareness of fertility issues and higher health care-seeking among individuals from more advantaged socioeconomic backgrounds. A potential higher, although modest and uncertain, risk of infertility following prenatal smoking exposure cannot be excluded, supporting the current guidelines recommending smoking cessation prior to pregnancy. STUDY FUNDING/COMPETING INTEREST(S): This study was funded by the European Union (ERC, BIOSFER, 101071773); expressed views and opinions are however those of the authors’ only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible for them. Additionally, this study received funding from Aarhus University and was supported by the Research Council of Norway, through its Centre of Excellence funding scheme (No. 262700). All authors have no conflicts or interests to declare. TRIAL REGISTRATION NUMBER: N/A.
- Open Access
- 8 December 2025
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2026 (1) , hoaf077
Atopic dermatitis and fecundity: a Danish National Birth Cohort study
STUDY QUESTION: Do women with atopic dermatitis have higher fecundity than those without? SUMMARY ANSWER: Pregnant women with a history of atopic dermatitis had a slightly shorter time-to-pregnancy (TTP) and a lower risk of conceiving using infertility treatment than those without. WHAT IS KNOWN ALREADY: Atopic dermatitis has a characteristic T-helper-2-cell-skewed immune response that mirrors the immune shift in pregnancy, which is necessary for the pregnant woman’s immune response to tolerate the fetus. Therefore, it has been hypothesized that atopic dermatitis may be advantageous for conception and pregnancy maintenance. However, this has not yet been investigated. STUDY DESIGN, SIZE, DURATION: This cohort study included 88 713 pregnant women from the population-based Danish National Birth Cohort (DNBC), who were enrolled between 1996 and 2002. PARTICIPANTS/MATERIALS, SETTING, METHODS: The women were defined as having atopic dermatitis if, in a computer-assisted interview conducted around gestational week 17, they reported having ever been diagnosed with atopic dermatitis by a doctor. The women were also asked whether the pregnancy was planned or unplanned, to report their TTP within one of five prespecified categories, and whether they had conceived with the use of infertility treatment. We used multinomial logistic regression models to assess associations between atopic dermatitis and fecundity in seven categories: (TTP 12 months, pregnant after infertility treatment or unplanned). In addition, we modeled TTP as dichotomous outcomes using logistic regression: subfecundity (TTP ≥6 months vs 12 months vs ≤12 months). We also assessed women with an atopic constitution (atopic dermatitis, allergic rhinitis, asthma, and food allergies), as this is associated with more severe atopic dermatitis. MAIN RESULTS AND THE ROLE OF CHANCE: Overall, 3641 (4.1%) women reported ever having had atopic dermatitis. Compared to women without atopic dermatitis, women with atopic dermatitis had a lower relative risk ratio (RRR) of having a TTP >12 months: 0.83 (95% CI: 0.72; 0.96), and use of infertility treatment, RRR: 0.81 (95% CI: 0.69; 0.94). Moreover, women with atopic dermatitis had a lower odds ratio (OR) of subfecundity: 0.89 (95% CI: 0.82; 0.96) and infertility: 0.85 (95% CI: 0.77; 0.95) than women without in the logistic regression model. Results were robust across several sub-analyses. LIMITATIONS, REASONS FOR CAUTION: The results can only be generalized to women who eventually conceive, since the DNBC consists only of women who successfully conceived. WIDER IMPLICATIONS OF THE FINDINGS: The findings support the hypothesis of an immunological benefit in conceiving when having atopic dermatitis. The results are reassuring for women with atopic dermatitis trying to conceive. However, the hypothesis should be further tested in a broader population of women without conditioning on pregnancy. STUDY FUNDING/COMPETING INTEREST(S): The work was supported by the Danish Council for Independent Research (grant number DFF—1030-00164B), Aarhus University, and Fonden af Fam. Kjærsgaard, Sunds, the Research Council of Norway (project no. 320656), through its Centres of Excellence funding scheme (project no. 262700), and co-funded by the European Union (ERC, BIOSFER, 101071773). However, views and opinions expressed herein are those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible. This publication is part of the ReproUnion collaborative study, co-financed by the European Union, Intereg V ÖKS (20200407). M.D. has received consulting fees (including participation on advisory boards) from AbbVie, LEO Pharma, Eli Lilly, Incyte, La Roche Posay, NUMAB Therapeutics, Pfizer, Regeneron Pharmaceuticals Inc., Sanofi Genzyme, Almirall, Union Therapeutics, Kymab, and UCB; travel support from LEO Pharma and Sanofi Genzyme; speaker fees from Mustela, Galderma, Leo Pharma, Sanofi Genzyme, and La Roche Posay; Section editor for Journal of the European Academy of Dermatology and Venereology (JEADV). None of these COIs is relevant to the present article. The remaining authors declare that they have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
- 8 December 2025
- Published by Oxford University Press (OUP) in Human Reproduction Open
- Vol. 2026 (1) , hoaf077
Open AccessAtopic dermatitis and fecundity: a Danish National Birth Cohort study
STUDY QUESTION: Do women with atopic dermatitis have higher fecundity than those without? SUMMARY ANSWER: Pregnant women with a history of atopic dermatitis had a slightly shorter time-to-pregnancy (TTP) and a lower risk of conceiving using infertility treatment than those without. WHAT IS KNOWN ALREADY: Atopic dermatitis has a characteristic T-helper-2-cell-skewed immune response that mirrors the immune shift in pregnancy, which is necessary for the pregnant woman’s immune response to tolerate the fetus. Therefore, it has been hypothesized that atopic dermatitis may be advantageous for conception and pregnancy maintenance. However, this has not yet been investigated. STUDY DESIGN, SIZE, DURATION: This cohort study included 88 713 pregnant women from the population-based Danish National Birth Cohort (DNBC), who were enrolled between 1996 and 2002. PARTICIPANTS/MATERIALS, SETTING, METHODS: The women were defined as having atopic dermatitis if, in a computer-assisted interview conducted around gestational week 17, they reported having ever been diagnosed with atopic dermatitis by a doctor. The women were also asked whether the pregnancy was planned or unplanned, to report their TTP within one of five prespecified categories, and whether they had conceived with the use of infertility treatment. We used multinomial logistic regression models to assess associations between atopic dermatitis and fecundity in seven categories: (TTP 12 months, pregnant after infertility treatment or unplanned). In addition, we modeled TTP as dichotomous outcomes using logistic regression: subfecundity (TTP ≥6 months vs 12 months vs ≤12 months). We also assessed women with an atopic constitution (atopic dermatitis, allergic rhinitis, asthma, and food allergies), as this is associated with more severe atopic dermatitis. MAIN RESULTS AND THE ROLE OF CHANCE: Overall, 3641 (4.1%) women reported ever having had atopic dermatitis. Compared to women without atopic dermatitis, women with atopic dermatitis had a lower relative risk ratio (RRR) of having a TTP >12 months: 0.83 (95% CI: 0.72; 0.96), and use of infertility treatment, RRR: 0.81 (95% CI: 0.69; 0.94). Moreover, women with atopic dermatitis had a lower odds ratio (OR) of subfecundity: 0.89 (95% CI: 0.82; 0.96) and infertility: 0.85 (95% CI: 0.77; 0.95) than women without in the logistic regression model. Results were robust across several sub-analyses. LIMITATIONS, REASONS FOR CAUTION: The results can only be generalized to women who eventually conceive, since the DNBC consists only of women who successfully conceived. WIDER IMPLICATIONS OF THE FINDINGS: The findings support the hypothesis of an immunological benefit in conceiving when having atopic dermatitis. The results are reassuring for women with atopic dermatitis trying to conceive. However, the hypothesis should be further tested in a broader population of women without conditioning on pregnancy. STUDY FUNDING/COMPETING INTEREST(S): The work was supported by the Danish Council for Independent Research (grant number DFF—1030-00164B), Aarhus University, and Fonden af Fam. Kjærsgaard, Sunds, the Research Council of Norway (project no. 320656), through its Centres of Excellence funding scheme (project no. 262700), and co-funded by the European Union (ERC, BIOSFER, 101071773). However, views and opinions expressed herein are those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council. Neither the European Union nor the granting authority can be held responsible. This publication is part of the ReproUnion collaborative study, co-financed by the European Union, Intereg V ÖKS (20200407). M.D. has received consulting fees (including participation on advisory boards) from AbbVie, LEO Pharma, Eli Lilly, Incyte, La Roche Posay, NUMAB Therapeutics, Pfizer, Regeneron Pharmaceuticals Inc., Sanofi Genzyme, Almirall, Union Therapeutics, Kymab, and UCB; travel support from LEO Pharma and Sanofi Genzyme; speaker fees from Mustela, Galderma, Leo Pharma, Sanofi Genzyme, and La Roche Posay; Section editor for Journal of the European Academy of Dermatology and Venereology (JEADV). None of these COIs is relevant to the present article. The remaining authors declare that they have no conflicts of interest. TRIAL REGISTRATION NUMBER: N/A.
- Open Access
- 16 April 2025
- Published by Elsevier in Annals of Epidemiology
- Vol. 106, 40-47
Maternal asthma in pregnancy and pubertal timing in daughters and sons: A population-based cohort study
- 16 April 2025
- Published by Elsevier in Annals of Epidemiology
- Vol. 106, 40-47
Open AccessMaternal asthma in pregnancy and pubertal timing in daughters and sons: A population-based cohort study
- Open Access
- 31 March 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (4) , 741-750
Atopic Dermatitis in Childhood and Biomarkers of Male Reproductive Health: A Danish National Birth Cohort Study
Background: Atopic dermatitis (AD) may be associated with male reproductive health. However, epidemiological studies are yet to explore this hypothesis.Objectives: To investigate whether AD in childhood is associated with poorer reproductive health in young men from the general population.Methods: This study is based on the Danish National Birth Cohort (DNBC) and its sub‐cohort, the Fetal Programming of Semen Quality cohort (FEPOS), which consists of young men born between 1998 and 2000 and whose mothers were included in the DNBC. In total, 5697 young men were invited during the recruitment period from 2017 to 2019, where 1058 were enroled and completed a comprehensive questionnaire regarding health and lifestyle, provided semen and blood samples and self‐measured their testicular volume. Information on maternal‐reported doctor‐diagnosed AD was obtained from the DNBC during childhood. The associations of semen characteristics, testicular volume and reproductive hormone levels with the occurrence of AD were analyzed using negative binomial and linear regression models.Results: In total, 220 (21%) young men had childhood AD. Men with childhood AD had slightly higher sperm concentration compared to those without (17%, 95% confidence intervals (CI): 3% to 33%), and lower FSH (−9%, 95% CI: −17% to 0%) and LH (−8%, 95% CI: −14% to −1%). Testosterone and estradiol levels and the remaining reproductive health outcomes were comparable between men with and without childhood AD.Conclusions: This study indicates that childhood AD might not have a clinically significant negative association with semen quality or reproductive hormone levels in young adulthood.
- 31 March 2025
- Published by Wiley in JEADV Clinical Practice
- Vol. 4 (4) , 741-750
Open AccessAtopic Dermatitis in Childhood and Biomarkers of Male Reproductive Health: A Danish National Birth Cohort Study
Background: Atopic dermatitis (AD) may be associated with male reproductive health. However, epidemiological studies are yet to explore this hypothesis.Objectives: To investigate whether AD in childhood is associated with poorer reproductive health in young men from the general population.Methods: This study is based on the Danish National Birth Cohort (DNBC) and its sub‐cohort, the Fetal Programming of Semen Quality cohort (FEPOS), which consists of young men born between 1998 and 2000 and whose mothers were included in the DNBC. In total, 5697 young men were invited during the recruitment period from 2017 to 2019, where 1058 were enroled and completed a comprehensive questionnaire regarding health and lifestyle, provided semen and blood samples and self‐measured their testicular volume. Information on maternal‐reported doctor‐diagnosed AD was obtained from the DNBC during childhood. The associations of semen characteristics, testicular volume and reproductive hormone levels with the occurrence of AD were analyzed using negative binomial and linear regression models.Results: In total, 220 (21%) young men had childhood AD. Men with childhood AD had slightly higher sperm concentration compared to those without (17%, 95% confidence intervals (CI): 3% to 33%), and lower FSH (−9%, 95% CI: −17% to 0%) and LH (−8%, 95% CI: −14% to −1%). Testosterone and estradiol levels and the remaining reproductive health outcomes were comparable between men with and without childhood AD.Conclusions: This study indicates that childhood AD might not have a clinically significant negative association with semen quality or reproductive hormone levels in young adulthood.
- Open Access
- 20 November 2024
- Published by Elsevier in JAAD International
- Vol. 19, 21-31
Atopic dermatitis in childhood and pubertal development: A nationwide cohort study
- 20 November 2024
- Published by Elsevier in JAAD International
- Vol. 19, 21-31
Open AccessAtopic dermatitis in childhood and pubertal development: A nationwide cohort study
- Open Access
- 1 February 2022
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 14, 149-157
Lifestyle in Pregnancy and Hypospadias in Sons: A Study of 85,923 Mother-Son Pairs from Two Danish Pregnancy Cohorts
Purpose: Hypospadias is one of the most frequent male congenital malformations. It remains controversial whether maternal lifestyle during pregnancy may affects the risk of having a son with hypospadias, especially for smoking with many suggesting lower risk. We assessed the individual and joint associations between maternal cigarette smoking, pre-pregnancy body mass index (BMI), alcohol consumption, binge drinking, and caffeine consumption and occurrence of hypospadias in sons. Patients and Methods: This cohort study utilized the Danish National Birth Cohort and the Aarhus Birth Cohort, holding detailed information on lifestyle factors in early pregnancy between 1989 and 2012. The Danish health registers were used to identify boys with hypospadias, according to International Classification of Diseases. Potential confounders and covariates were identified by literature search and use of directed acyclic graphs. Missing data were handled by multiple imputation and Cox proportional hazards models were applied to analyse data. Results: In total, 85,923 live-born singleton boys were included in the study of whom 502 (0.6%) were diagnosed with hypospadias. Maternal smoking in early pregnancy was associated with lower occurrence of hypospadias. An increase of one cigarette smoked per day was associated with lower risk of having a son with hypospadias (adjusted hazard ratio (HR) 0.97 (95% confidence interval (CI) 0.94, 1.00)). However, sub-analyses suggested that the results may be prone to unadjusted confounding. We found no association between pre-pregnancy BMI, alcohol consumption, binge drinking, or caffeine consumption and hypospadias. Conclusion: Maternal smoking during pregnancy was associated with lower occurrence of hypospadias but we cannot exclude uncontrolled confounding. The other investigated maternal lifestyle factors were not associated with hypospadias in sons.
- 1 February 2022
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. ume 14, 149-157
Open AccessLifestyle in Pregnancy and Hypospadias in Sons: A Study of 85,923 Mother-Son Pairs from Two Danish Pregnancy Cohorts
Purpose: Hypospadias is one of the most frequent male congenital malformations. It remains controversial whether maternal lifestyle during pregnancy may affects the risk of having a son with hypospadias, especially for smoking with many suggesting lower risk. We assessed the individual and joint associations between maternal cigarette smoking, pre-pregnancy body mass index (BMI), alcohol consumption, binge drinking, and caffeine consumption and occurrence of hypospadias in sons. Patients and Methods: This cohort study utilized the Danish National Birth Cohort and the Aarhus Birth Cohort, holding detailed information on lifestyle factors in early pregnancy between 1989 and 2012. The Danish health registers were used to identify boys with hypospadias, according to International Classification of Diseases. Potential confounders and covariates were identified by literature search and use of directed acyclic graphs. Missing data were handled by multiple imputation and Cox proportional hazards models were applied to analyse data. Results: In total, 85,923 live-born singleton boys were included in the study of whom 502 (0.6%) were diagnosed with hypospadias. Maternal smoking in early pregnancy was associated with lower occurrence of hypospadias. An increase of one cigarette smoked per day was associated with lower risk of having a son with hypospadias (adjusted hazard ratio (HR) 0.97 (95% confidence interval (CI) 0.94, 1.00)). However, sub-analyses suggested that the results may be prone to unadjusted confounding. We found no association between pre-pregnancy BMI, alcohol consumption, binge drinking, or caffeine consumption and hypospadias. Conclusion: Maternal smoking during pregnancy was associated with lower occurrence of hypospadias but we cannot exclude uncontrolled confounding. The other investigated maternal lifestyle factors were not associated with hypospadias in sons.
- Open Access
- 1 January 2018
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. 10, 311-322
Lifestyle in pregnancy and cryptorchidism in sons: a study within two large Danish birth cohorts
Purpose: Cryptorchidism is the most frequent congenital malformation in boys and is associated with low sperm count, infertility and testicular cancer. Unhealthy maternal lifestyle during pregnancy such as smoking, high prepregnancy body mass index (BMI) as well as alcohol and caffeine intake may constitute possible risk factors for cryptorchidism, but results from the few previous studies are conflicting. We aimed to explore the association between maternal lifestyle factors and occurrence of cryptorchidism in sons. Patients and methods: The Danish National Birth Cohort and the Aarhus Birth Cohort provided information on maternal lifestyle from early pregnancy. Data were linked to several Danish health registers, multiple imputation was used to handle missing data and Cox proportional hazards models were used to adjust for potential confounders. Results: In total, 85,923 boys were included, and of them, 2.2% were diagnosed with cryptorchidism. We observed the strongest associations between maternal tobacco smoking and prepregnancy BMI and cryptorchidism. Sons of women who smoked 10-14 cigarettes/day had the highest hazard ratio (HR) for cryptorchidism (1.37; 95% CI: 1.06-1.76), and for maternal BMI >= 30 kg/m(2), the HR was 1.32 (95% CI: 1.06-1.65). Binge drinking was associated with an HR <1, if the women had one or two episodes in pregnancy (HR: 0.81; 95% CI: 0.67-0.98). Average maternal alcohol intake and caffeine intake during pregnancy were not significantly associated with a higher occurrence of cryptorchidism detected at birth or later in life. Conclusion: Maternal tobacco smoking, overweight and obesity in pregnancy were associated with higher occurrence of cryptorchidism in boys in this study.
- 1 January 2018
- Published by Taylor & Francis in Clinical Epidemiology
- Vol. 10, 311-322
Open AccessLifestyle in pregnancy and cryptorchidism in sons: a study within two large Danish birth cohorts
Purpose: Cryptorchidism is the most frequent congenital malformation in boys and is associated with low sperm count, infertility and testicular cancer. Unhealthy maternal lifestyle during pregnancy such as smoking, high prepregnancy body mass index (BMI) as well as alcohol and caffeine intake may constitute possible risk factors for cryptorchidism, but results from the few previous studies are conflicting. We aimed to explore the association between maternal lifestyle factors and occurrence of cryptorchidism in sons. Patients and methods: The Danish National Birth Cohort and the Aarhus Birth Cohort provided information on maternal lifestyle from early pregnancy. Data were linked to several Danish health registers, multiple imputation was used to handle missing data and Cox proportional hazards models were used to adjust for potential confounders. Results: In total, 85,923 boys were included, and of them, 2.2% were diagnosed with cryptorchidism. We observed the strongest associations between maternal tobacco smoking and prepregnancy BMI and cryptorchidism. Sons of women who smoked 10-14 cigarettes/day had the highest hazard ratio (HR) for cryptorchidism (1.37; 95% CI: 1.06-1.76), and for maternal BMI >= 30 kg/m(2), the HR was 1.32 (95% CI: 1.06-1.65). Binge drinking was associated with an HR <1, if the women had one or two episodes in pregnancy (HR: 0.81; 95% CI: 0.67-0.98). Average maternal alcohol intake and caffeine intake during pregnancy were not significantly associated with a higher occurrence of cryptorchidism detected at birth or later in life. Conclusion: Maternal tobacco smoking, overweight and obesity in pregnancy were associated with higher occurrence of cryptorchidism in boys in this study.